GlassScriptPhysician profile
Jessica A Mitchell
NPI 1639695497
$5,248.94
in general payments reported to CMS, 2019-2025
26 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,057 · 2022: $1,172 · 2023: $923 · 2024: $1,907 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,019.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $906.81 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $680.49 | 2021-2025 | |
| Abbott Laboratories | $499.18 | 2021-2024 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Itamar Medical INC | $475.89 | 2021-2024 | Watchpatone |
| Janssen Pharmaceuticals, INC | $397.70 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $246.56 | 2021-2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $227.38 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.42 | 2021-2023 | Jardiance |
| Kestra Medical Technology Services, INC. | $191.68 | 2024 | Assure Wcd |
| Abiomed | $182.29 | 2024 | Impella |
| Impulse Dynamics (USA) INC. | $175.86 | 2024 | Optimizer |
| Heartflow, INC. | $146.01 | 2024 | |
| Atricure, INC. | $141.60 | 2024 | |
| Merck Sharp & Dohme LLC | $136.18 | 2022-2023 | Verquvo |
| Esperion Therapeutics, INC. | $133.51 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $98.98 | 2024 | Corevalve Evolut R |
| Kiniksa Pharmaceuticals, LTD. | $91.92 | 2021-2023 | Arcalyst |
| Amgen INC. | $79.72 | 2023-2024 | Repatha |
| Boston Scientific Corporation | $45.05 | 2024 | Vigilant X4 Crt-D |
| Bard Peripheral Vascular, INC. | $45.01 | 2022 | |
| Sanofi-Aventis U.S. LLC | $37.28 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $25.96 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $24.20 | 2024 | Opsumit, Uptravi |
| Scpharmaceuticals INC. | $23.57 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $18.31 | 2024 | Arcalyst |
| Biosense Webster, INC. | $5.38 | 2024 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.